22,135,656
Vote Records
28,570
Companies
12,092
Funds
3,981
Managers

Home › Companies › WAVE LIFE SCIENCES LTD. › 2024-2025

WAVE LIFE SCIENCES LTD. 2024-2025 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and WAVE LIFE SCIENCES LTD.’s Form 8-K, filed August 12, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 14Ballot items
  • 141Asset managers, any item
  • 1,817Fund votes
  • August 6, 2024Meeting date

Results at a glance

Meeting of August 6, 2024: 14 items on WAVE LIFE SCIENCES LTD.’s Form 8-K, filed August 12, 2024: 5 approved · 9 passed (calculated).

Dissent

Notable dissent: 2 directors (14.7%, 10.5% against).

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Activist investors: Ra Capital Management, L.P. (13D, 16.8%, as of August 11, 2026)

Explore WAVE LIFE SCIENCES LTD. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by WAVE LIFE SCIENCES LTD.

These tallies are WAVE LIFE SCIENCES LTD.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed August 12, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

WAVE LIFE SCIENCES LTD. — official shareholder meeting results, meeting held August 6, 2024
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Paul B. Bolno, M.D., MBA 94,216,416311,6449,938 --7,561,358 99.7%Passed (calculated)—
Elect Director: Mark H.N. Corrigan, M.D. 94,064,384464,4749,140 --7,561,358 99.5%Passed (calculated)—
Elect Director: Christian Henry 80,627,62013,894,73715,641 --7,561,358 85%Passed (calculated)—
Elect Director: Peter Kolchinsky, Ph.D. 94,208,852320,0069,140 --7,561,358 99.7%Passed (calculated)—
Elect Director: Adrian Rawcliffe 94,204,112317,71616,170 --7,561,358 99.7%Passed (calculated)—
Elect Director: Ken Takanashi 84,642,7619,879,21616,021 --7,561,358 90%Passed (calculated)—
Elect Director: Aik Na Tan 94,212,680309,17816,140 --7,561,358 99.7%Passed (calculated)—
Elect Director: Gregory L. Verdine, Ph.D. 93,743,298781,48913,211 --7,561,358 99.2%Passed (calculated)—
Elect Director: Heidi L. Wagner, J.D. 91,335,0133,179,84823,137 --7,561,358 97%Passed (calculated)—
2. The re-appointment of KPMG LLP to serve as the Company's independent registered public accounting firm and independent Singapore auditor for the year ending December 31, 2024, and to authorize the Audit Committee of the Board of Directors to fix 101,761,729316,57621,051 --0 99.7%Approved—
3. Company's payment of cash and equity-based compensation to the Company's non-employee directors for their service on the Board of Directors and its committees, in the manner and on the basis set forth in the Proxy Statement, with the final vo 94,323,501195,60618,891 --7,561,358 99.8%Approved—
4. The amendment to the Company's 2021 Equity Incentive Plan, as amended, in the manner and on the basis set forth in the Proxy Statement, with the final votes cast 82,321,91212,184,06932,017 --7,561,358 87%Approved—
5. A general authorization for the directors of the Company to allot and issue ordinary shares of the Company, in the manner and on the basis set forth in the Proxy Statement, with the final votes cast 80,951,34113,571,38315,274 --7,561,358 86%Approved—
6. On a non-binding, advisory basis only, the compensation of the Company's named executive officers, in the manner and on the basis set forth described in the Proxy Statement, with the final votes cast 94,163,361356,57318,064 --7,561,358 99.6%Approved—

Source: WAVE LIFE SCIENCES LTD., Form 8-K, filed with the SEC on August 12, 2024 — read the filing on EDGAR.

How asset managers voted at the WAVE LIFE SCIENCES LTD. 2024-2025 meeting

141 asset managers disclosed a vote on at least one WAVE LIFE SCIENCES LTD. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.

Elect Director: Adrian Rawcliffe

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 3 wordings of this item as funds reported it.

99.7% Majority: yes · of votes cast

FOR 99.7%
FOR: 94,204,112AGAINST: 317,716

Prior year: 100.0% for (August 1, 2023 meeting) ▼ 0.3 pts

Details: description as filed, official tally, votes by 40 asset managers

Description as filed by funds: The election of the nominees for director: Adrian Rawcliffe

WAVE LIFE SCIENCES LTD.’s own tally for this item (“Elect Director: Adrian Rawcliffe”): 94,204,112 for, 317,716 against, per its Form 8-K filed August 12, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 40 asset managers below reported 13,771,052 for.

FOR
FOR: 13,771,052
Largest asset managers voting on “The election of the nominees for director: Adrian Rawcliffe” at WAVE LIFE SCIENCES LTD., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock3,198,0300 00For
PRIMECAP Odyssey Funds2,544,7000 00For
Fidelity2,434,2230 00For
Vanguard1,851,6790 00For
T. Rowe Price1,420,5910 00For
Principal478,5670 00For
Charles Schwab356,0920 00For
SEI222,6820 00For
TIAA215,3110 00For
Prudential/PGIM158,6280 00For
QUANTITATIVE MASTER SERIES LLC154,3850 00For
John Hancock81,9930 00For
Delaware/Macquarie81,9550 00For
Equitable66,0520 00For
Lincoln Financial50,1000 00For
Putnam48,5930 00For
AIG/SunAmerica45,2760 00For
Northern Trust38,5540 00For
Global X33,2800 00For
State Street31,2780 00For
New York Life29,9280 00For
Pacific Life29,6600 00For
Nationwide26,3680 00For
Columbia Threadneedle25,9940 00For
Voya22,8830 00For

Showing the 25 largest of 40 asset managers. All 40 are in the interactive database (link above).

Elect Director: Aik Na Tan

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 3 wordings of this item as funds reported it.

99.7% Majority: yes · of votes cast

FOR 99.7%
FOR: 94,212,680AGAINST: 309,178

Prior year: 91.4% for (August 1, 2023 meeting) ▲ 8.3 pts

Details: description as filed, official tally, votes by 40 asset managers

Description as filed by funds: The election of the nominees for director: Aik Na Tan

WAVE LIFE SCIENCES LTD.’s own tally for this item (“Elect Director: Aik Na Tan”): 94,212,680 for, 309,178 against, per its Form 8-K filed August 12, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 40 asset managers below reported 13,771,052 for.

FOR
FOR: 13,771,052
Largest asset managers voting on “The election of the nominees for director: Aik Na Tan” at WAVE LIFE SCIENCES LTD., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock3,198,0300 00For
PRIMECAP Odyssey Funds2,544,7000 00For
Fidelity2,434,2230 00For
Vanguard1,851,6790 00For
T. Rowe Price1,420,5910 00For
Principal478,5670 00For
Charles Schwab356,0920 00For
SEI222,6820 00For
TIAA215,3110 00For
Prudential/PGIM158,6280 00For
QUANTITATIVE MASTER SERIES LLC154,3850 00For
John Hancock81,9930 00For
Delaware/Macquarie81,9550 00For
Equitable66,0520 00For
Lincoln Financial50,1000 00For
Putnam48,5930 00For
AIG/SunAmerica45,2760 00For
Northern Trust38,5540 00For
Global X33,2800 00For
State Street31,2780 00For
New York Life29,9280 00For
Pacific Life29,6600 00For
Nationwide26,3680 00For
Columbia Threadneedle25,9940 00For
Voya22,8830 00For

Showing the 25 largest of 40 asset managers. All 40 are in the interactive database (link above).

Elect Director: Christian Henry

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 3 wordings of this item as funds reported it.

85% Majority: yes · of votes cast

FOR 85%AGAINST
FOR: 80,627,620AGAINST: 13,894,737

Prior year: 96.2% for (August 1, 2023 meeting) ▼ 10.9 pts

Details: description as filed, official tally, votes by 40 asset managers

Description as filed by funds: The election of the nominees for director: Christian Henry

WAVE LIFE SCIENCES LTD.’s own tally for this item (“Elect Director: Christian Henry”): 80,627,620 for, 13,894,737 against, per its Form 8-K filed August 12, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 85% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 40 asset managers below reported 6,106,294 for, 7,664,758 against.

FORAGAINST
FOR: 6,106,294AGAINST: 7,664,758
Largest asset managers voting on “The election of the nominees for director: Christian Henry” at WAVE LIFE SCIENCES LTD., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock03,198,030 00Against
PRIMECAP Odyssey Funds2,544,7000 00For
Fidelity2,393,28540,938 00For
Vanguard01,851,679 00Against
T. Rowe Price01,420,591 00Against
Principal478,327240 00For
Charles Schwab0356,092 00Against
SEI0222,682 00Against
TIAA215,3110 00For
Prudential/PGIM158,6280 00For
QUANTITATIVE MASTER SERIES LLC0154,385 00Against
John Hancock28,19153,802 00Mixed
Delaware/Macquarie81,9550 00For
Equitable066,052 00Against
Lincoln Financial050,100 00Against
Putnam48,5930 00For
AIG/SunAmerica45,2760 00For
Northern Trust038,554 00Against
Global X033,280 00Against
State Street031,278 00Against
New York Life029,928 00Against
Pacific Life029,660 00Against
Nationwide25,2591,109 00For
Columbia Threadneedle025,994 00Against
Voya022,883 00Against

Showing the 25 largest of 40 asset managers. All 40 are in the interactive database (link above).

Elect Director: Gregory L. Verdine, Ph.D.

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 3 wordings of this item as funds reported it.

99.2% Majority: yes · of votes cast

FOR 99.2%
FOR: 93,743,298AGAINST: 781,489

Prior year: 91.3% for (August 1, 2023 meeting) ▲ 7.8 pts

Details: description as filed, official tally, votes by 40 asset managers

Description as filed by funds: The election of the nominees for director: Gregory L. Verdine, Ph.D.

WAVE LIFE SCIENCES LTD.’s own tally for this item (“Elect Director: Gregory L. Verdine, Ph.D.”): 93,743,298 for, 781,489 against, per its Form 8-K filed August 12, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.2% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 40 asset managers below reported 13,771,052 for.

FOR
FOR: 13,771,052
Largest asset managers voting on “The election of the nominees for director: Gregory L. Verdine, Ph.D.” at WAVE LIFE SCIENCES LTD., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock3,198,0300 00For
PRIMECAP Odyssey Funds2,544,7000 00For
Fidelity2,434,2230 00For
Vanguard1,851,6790 00For
T. Rowe Price1,420,5910 00For
Principal478,5670 00For
Charles Schwab356,0920 00For
SEI222,6820 00For
TIAA215,3110 00For
Prudential/PGIM158,6280 00For
QUANTITATIVE MASTER SERIES LLC154,3850 00For
John Hancock81,9930 00For
Delaware/Macquarie81,9550 00For
Equitable66,0520 00For
Lincoln Financial50,1000 00For
Putnam48,5930 00For
AIG/SunAmerica45,2760 00For
Northern Trust38,5540 00For
Global X33,2800 00For
State Street31,2780 00For
New York Life29,9280 00For
Pacific Life29,6600 00For
Nationwide26,3680 00For
Columbia Threadneedle25,9940 00For
Voya22,8830 00For

Showing the 25 largest of 40 asset managers. All 40 are in the interactive database (link above).

Elect Director: Heidi L. Wagner, J.D.

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 3 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 91,335,013AGAINST: 3,179,848

Prior year: 99.5% for (August 1, 2023 meeting) ▼ 2.9 pts

Details: description as filed, official tally, votes by 40 asset managers

Description as filed by funds: The election of the nominees for director: Heidi L. Wagner, J.D.

WAVE LIFE SCIENCES LTD.’s own tally for this item (“Elect Director: Heidi L. Wagner, J.D.”): 91,335,013 for, 3,179,848 against, per its Form 8-K filed August 12, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 40 asset managers below reported 13,313,686 for, 457,366 against.

FOR
FOR: 13,313,686AGAINST: 457,366
Largest asset managers voting on “The election of the nominees for director: Heidi L. Wagner, J.D.” at WAVE LIFE SCIENCES LTD., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock3,198,0300 00For
PRIMECAP Odyssey Funds2,544,7000 00For
Fidelity2,434,2230 00For
Vanguard1,851,6790 00For
T. Rowe Price1,420,5910 00For
Principal478,5670 00For
Charles Schwab356,0920 00For
SEI0222,682 00Against
TIAA215,3110 00For
Prudential/PGIM158,6280 00For
QUANTITATIVE MASTER SERIES LLC154,3850 00For
John Hancock81,9930 00For
Delaware/Macquarie081,955 00Against
Equitable66,0520 00For
Lincoln Financial050,100 00Against
Putnam48,5930 00For
AIG/SunAmerica45,2760 00For
Northern Trust38,5540 00For
Global X033,280 00Against
State Street031,278 00Against
New York Life29,9280 00For
Pacific Life29,6600 00For
Nationwide26,3680 00For
Columbia Threadneedle025,994 00Against
Voya22,8830 00For

Showing the 25 largest of 40 asset managers. All 40 are in the interactive database (link above).

Elect Director: Ken Takanashi

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 3 wordings of this item as funds reported it.

90% Majority: yes · of votes cast

FOR 90%
FOR: 84,642,761AGAINST: 9,879,216

Prior year: 88.3% for (August 1, 2023 meeting) ▲ 1.2 pts

Details: description as filed, official tally, votes by 40 asset managers

Description as filed by funds: The election of the nominees for director: Ken Takanashi

WAVE LIFE SCIENCES LTD.’s own tally for this item (“Elect Director: Ken Takanashi”): 84,642,761 for, 9,879,216 against, per its Form 8-K filed August 12, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 90% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 40 asset managers below reported 9,500,891 for, 4,270,161 against.

FORAGAINST
FOR: 9,500,891AGAINST: 4,270,161
Largest asset managers voting on “The election of the nominees for director: Ken Takanashi” at WAVE LIFE SCIENCES LTD., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock03,198,030 00Against
PRIMECAP Odyssey Funds2,544,7000 00For
Fidelity2,393,28540,938 00For
Vanguard1,851,6790 00For
T. Rowe Price1,420,5910 00For
Principal478,327240 00For
Charles Schwab0356,092 00Against
SEI0222,682 00Against
TIAA215,3110 00For
Prudential/PGIM158,6280 00For
QUANTITATIVE MASTER SERIES LLC0154,385 00Against
John Hancock81,9930 00For
Delaware/Macquarie81,9550 00For
Equitable31,95434,098 00Mixed
Lincoln Financial050,100 00Against
Putnam48,5930 00For
AIG/SunAmerica45,2760 00For
Northern Trust038,554 00Against
Global X033,280 00Against
State Street031,278 00Against
New York Life029,928 00Against
Pacific Life029,660 00Against
Nationwide25,2591,109 00For
Columbia Threadneedle25,9940 00For
Voya022,883 00Against

Showing the 25 largest of 40 asset managers. All 40 are in the interactive database (link above).

Elect Director: Mark H.N. Corrigan, M.D.

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 3 wordings of this item as funds reported it.

99.5% Majority: yes · of votes cast

FOR 99.5%
FOR: 94,064,384AGAINST: 464,474

Prior year: 99.9% for (August 1, 2023 meeting) ▼ 0.4 pts

Details: description as filed, official tally, votes by 40 asset managers

Description as filed by funds: The election of the nominees for director: Mark H. N. Corrigan, M.D.

WAVE LIFE SCIENCES LTD.’s own tally for this item (“Elect Director: Mark H.N. Corrigan, M.D.”): 94,064,384 for, 464,474 against, per its Form 8-K filed August 12, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 40 asset managers below reported 13,771,052 for.

FOR
FOR: 13,771,052
Largest asset managers voting on “The election of the nominees for director: Mark H. N. Corrigan, M.D.” at WAVE LIFE SCIENCES LTD., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock3,198,0300 00For
PRIMECAP Odyssey Funds2,544,7000 00For
Fidelity2,434,2230 00For
Vanguard1,851,6790 00For
T. Rowe Price1,420,5910 00For
Principal478,5670 00For
Charles Schwab356,0920 00For
SEI222,6820 00For
TIAA215,3110 00For
Prudential/PGIM158,6280 00For
QUANTITATIVE MASTER SERIES LLC154,3850 00For
John Hancock81,9930 00For
Delaware/Macquarie81,9550 00For
Equitable66,0520 00For
Lincoln Financial50,1000 00For
Putnam48,5930 00For
AIG/SunAmerica45,2760 00For
Northern Trust38,5540 00For
Global X33,2800 00For
State Street31,2780 00For
New York Life29,9280 00For
Pacific Life29,6600 00For
Nationwide26,3680 00For
Columbia Threadneedle25,9940 00For
Voya22,8830 00For

Showing the 25 largest of 40 asset managers. All 40 are in the interactive database (link above).

Elect Director: Paul B. Bolno, M.D., MBA

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 3 wordings of this item as funds reported it.

99.7% Majority: yes · of votes cast

FOR 99.7%
FOR: 94,216,416AGAINST: 311,644

Prior year: 99.8% for (August 1, 2023 meeting) ▼ 0.2 pts

Details: description as filed, official tally, votes by 40 asset managers

Description as filed by funds: The election of the nominees for director: Paul B. Bolno, M.D., MBA

WAVE LIFE SCIENCES LTD.’s own tally for this item (“Elect Director: Paul B. Bolno, M.D., MBA”): 94,216,416 for, 311,644 against, per its Form 8-K filed August 12, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 40 asset managers below reported 13,771,052 for.

FOR
FOR: 13,771,052
Largest asset managers voting on “The election of the nominees for director: Paul B. Bolno, M.D., MBA” at WAVE LIFE SCIENCES LTD., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock3,198,0300 00For
PRIMECAP Odyssey Funds2,544,7000 00For
Fidelity2,434,2230 00For
Vanguard1,851,6790 00For
T. Rowe Price1,420,5910 00For
Principal478,5670 00For
Charles Schwab356,0920 00For
SEI222,6820 00For
TIAA215,3110 00For
Prudential/PGIM158,6280 00For
QUANTITATIVE MASTER SERIES LLC154,3850 00For
John Hancock81,9930 00For
Delaware/Macquarie81,9550 00For
Equitable66,0520 00For
Lincoln Financial50,1000 00For
Putnam48,5930 00For
AIG/SunAmerica45,2760 00For
Northern Trust38,5540 00For
Global X33,2800 00For
State Street31,2780 00For
New York Life29,9280 00For
Pacific Life29,6600 00For
Nationwide26,3680 00For
Columbia Threadneedle25,9940 00For
Voya22,8830 00For

Showing the 25 largest of 40 asset managers. All 40 are in the interactive database (link above).

Elect Director: Peter Kolchinsky, Ph.D.

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 3 wordings of this item as funds reported it.

99.7% Majority: yes · of votes cast

FOR 99.7%
FOR: 94,208,852AGAINST: 320,006

Prior year: 99.8% for (August 1, 2023 meeting) ▼ 0.2 pts

Details: description as filed, official tally, votes by 40 asset managers

Description as filed by funds: The election of the nominees for director: Peter Kolchinsky, Ph.D.

WAVE LIFE SCIENCES LTD.’s own tally for this item (“Elect Director: Peter Kolchinsky, Ph.D.”): 94,208,852 for, 320,006 against, per its Form 8-K filed August 12, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 40 asset managers below reported 13,771,052 for.

FOR
FOR: 13,771,052
Largest asset managers voting on “The election of the nominees for director: Peter Kolchinsky, Ph.D.” at WAVE LIFE SCIENCES LTD., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock3,198,0300 00For
PRIMECAP Odyssey Funds2,544,7000 00For
Fidelity2,434,2230 00For
Vanguard1,851,6790 00For
T. Rowe Price1,420,5910 00For
Principal478,5670 00For
Charles Schwab356,0920 00For
SEI222,6820 00For
TIAA215,3110 00For
Prudential/PGIM158,6280 00For
QUANTITATIVE MASTER SERIES LLC154,3850 00For
John Hancock81,9930 00For
Delaware/Macquarie81,9550 00For
Equitable66,0520 00For
Lincoln Financial50,1000 00For
Putnam48,5930 00For
AIG/SunAmerica45,2760 00For
Northern Trust38,5540 00For
Global X33,2800 00For
State Street31,2780 00For
New York Life29,9280 00For
Pacific Life29,6600 00For
Nationwide26,3680 00For
Columbia Threadneedle25,9940 00For
Voya22,8830 00For

Showing the 25 largest of 40 asset managers. All 40 are in the interactive database (link above).

A general authorization for the directors of the Company to allot and issue ordinary shares of the Company, in the…

Official resultFund totals may overlapCAPITAL STRUCTUREReported outcome: Approved

86% Approved · of votes cast

FOR 86%AGAINST
FOR: 80,951,341AGAINST: 13,571,383
Details: description as filed, official tally, votes by 41 asset managers

Description as filed by funds: To authorize the Board of Directors to allot and issue Ordinary Shares of Wave Life Sciences Ltd.

WAVE LIFE SCIENCES LTD.’s own tally for this item (“5. A general authorization for the directors of the Company to allot and issue ordinary shares of the Company, in the manner and on the basis set forth in the Proxy Statement, with the final votes cast”): 80,951,341 for, 13,571,383 against — passed, per its Form 8-K filed August 12, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 5 - Shareholders approved a general authorization for the directors of the Company to allot and issue ordinary shares of the Company, in the manner and on the basis set forth in the Proxy Statement, with the final votes cast as follows:”
Support: 86% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 40 asset managers voting on “To authorize the Board of Directors to allot and issue Ordinary Shares of Wave Life Sciences Ltd.” at WAVE LIFE SCIENCES LTD., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock3,198,0300 00For
PRIMECAP Odyssey Funds2,544,7000 00For
Fidelity2,434,2230 00For
Vanguard1,851,6790 00For
T. Rowe Price01,420,591 00Against
Principal478,5670 00For
Charles Schwab356,0920 00For
SEI222,6820 00For
TIAA0215,311 00Against
Prudential/PGIM158,6280 00For
QUANTITATIVE MASTER SERIES LLC154,3850 00For
John Hancock081,993 00Against
Delaware/Macquarie081,955 00Against
Equitable34,09831,954 00Mixed
Lincoln Financial050,100 00Against
Putnam048,593 00Against
AIG/SunAmerica045,276 00Against
Northern Trust038,554 00Against
Global X33,2800 00For
State Street031,278 00Against
New York Life29,9280 00For
Pacific Life29,6600 00For
Nationwide1,10925,259 00Against
Columbia Threadneedle025,994 00Against
Voya022,883 00Against

Fund voting reports, all 40 managers: 11,549,222 for, 2,221,830 against. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 1 asset manager voting on “To authorize the Board of Directors to allot and issue Ordinary Shares of Wave Life Sciences Ltd.” at WAVE LIFE SCIENCES LTD., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Kynam Capital Management, LP3,932,5500 00For

Institutional-manager reports, all 1 managers: 3,932,550 for.

The amendment to the Company's 2021 Equity Incentive Plan, as amended, in the manner and on the basis set forth in the…

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 2 wordings of this item as funds reported it.

87% Approved · of votes cast

FOR 87%
FOR: 82,321,912AGAINST: 12,184,069

Prior year: 99.0% for (August 1, 2023 meeting) ▼ 11.8 pts

Details: description as filed, official tally, votes by 43 asset managers

Description as filed by funds: To approve a proposed amendment to our 2021 Equity Incentive Plan, as amended, in the manner and on the basis as set forth under "Proposal 4: Approval of an Amendment to the 2021 Equity Incentive Plan, as amended" in the proxy statement

WAVE LIFE SCIENCES LTD.’s own tally for this item (“4. The amendment to the Company's 2021 Equity Incentive Plan, as amended, in the manner and on the basis set forth in the Proxy Statement, with the final votes cast”): 82,321,912 for, 12,184,069 against — passed, per its Form 8-K filed August 12, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 4 - Shareholders approved the amendment to the Company's 2021 Equity Incentive Plan, as amended, in the manner and on the basis set forth in the Proxy Statement, with the final votes cast as follows:”
Support: 87% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 40 asset managers voting on “To approve a proposed amendment to our 2021 Equity Incentive Plan, as amended, in the manner and on the basis ” at WAVE LIFE SCIENCES LTD., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock3,198,0300 00For
PRIMECAP Odyssey Funds2,544,7000 00For
Fidelity1,832,307601,916 00Mixed
Vanguard1,851,6790 00For
T. Rowe Price01,420,591 00Against
Principal478,5670 00For
Charles Schwab356,0920 00For
SEI222,6820 00For
TIAA215,3110 00For
Prudential/PGIM158,6280 00For
QUANTITATIVE MASTER SERIES LLC154,3850 00For
John Hancock081,993 00Against
Delaware/Macquarie081,955 00Against
Equitable61,4484,604 00Mixed
Lincoln Financial50,1000 00For
Putnam048,593 00Against
AIG/SunAmerica045,276 00Against
Northern Trust038,554 00Against
Global X33,2800 00For
State Street31,2780 00For
New York Life29,9280 00For
Pacific Life29,6600 00For
Nationwide1,10925,259 00Against
Columbia Threadneedle025,994 00Against
Voya022,883 00Against

Fund voting reports, all 40 managers: 11,283,623 for, 2,487,429 against. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 2 asset managers voting on “To approve a proposed amendment to our 2021 Equity Incentive Plan, as amended, in the manner and on the basis ” at WAVE LIFE SCIENCES LTD., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Kynam Capital Management, LP3,932,5500 00For
UNITED CAPITAL FINANCIAL ADVISORS, LLC07,968 00Against

Institutional-manager reports, all 2 managers: 3,932,550 for, 7,968 against.

Company's payment of cash and equity-based compensation to the Company's non-employee directors for their service on…

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 3 wordings of this item as funds reported it.

99.8% Approved · of votes cast

FOR 99.8%
FOR: 94,323,501AGAINST: 195,606
Details: description as filed, official tally, votes by 43 asset managers

Description as filed by funds: To approve our payment of cash and equity-based compensation to non-employee directors for service on the Board of Directors and its committees, in the manner and on the basis set forth under "Proposal 3: Non- Employee Directors' Compensation" in the proxy statement

WAVE LIFE SCIENCES LTD.’s own tally for this item (“3. The Company's payment of cash and equity-based compensation to the Company's non-employee directors for their service on the Board of Directors and its committees, in the manner and on the basis set forth in the Proxy”): 94,323,501 for, 195,606 against — passed, per its Form 8-K filed August 12, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 3 - Shareholders approved the Company's payment of cash and equity-based compensation to the Company's non-employee directors for their service on the Board of Directors and its committees, in the manner and on the basis set forth in the Proxy Statement, with the final votes cast as follow…”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 40 asset managers voting on “To approve our payment of cash and equity-based compensation to non-employee directors for service on the Boar” at WAVE LIFE SCIENCES LTD., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock3,198,0300 00For
PRIMECAP Odyssey Funds2,544,7000 00For
Fidelity2,434,2230 00For
Vanguard1,851,6790 00For
T. Rowe Price1,420,5910 00For
Principal478,5670 00For
Charles Schwab356,0920 00For
SEI222,6820 00For
TIAA215,3110 00For
Prudential/PGIM158,6280 00For
QUANTITATIVE MASTER SERIES LLC154,3850 00For
John Hancock81,9930 00For
Delaware/Macquarie81,9550 00For
Equitable66,0520 00For
Lincoln Financial50,1000 00For
Putnam48,5930 00For
AIG/SunAmerica45,2760 00For
Northern Trust38,5540 00For
Global X33,2800 00For
State Street31,2780 00For
New York Life29,9280 00For
Pacific Life29,6600 00For
Nationwide26,3680 00For
Columbia Threadneedle25,9940 00For
Voya22,8830 00For

Fund voting reports, all 40 managers: 13,771,052 for. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 2 asset managers voting on “To approve our payment of cash and equity-based compensation to non-employee directors for service on the Boar” at WAVE LIFE SCIENCES LTD., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Kynam Capital Management, LP3,932,5500 00For
UNITED CAPITAL FINANCIAL ADVISORS, LLC7,9680 00For

Institutional-manager reports, all 2 managers: 3,940,518 for.

On a non-binding, advisory basis only, the compensation of the Company's named executive officers, in the manner and on…

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 3 wordings of this item as funds reported it.

99.6% Approved · of votes cast

FOR 99.6%
FOR: 94,163,361AGAINST: 356,573

Prior year: 99.8% for (August 1, 2023 meeting) ▼ 0.2 pts

Details: description as filed, official tally, votes by 138 asset managers

Description as filed by funds: TO APPROVE, BY A NON-BINDING ADVISORY VOTE, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE PROXY STATEMENT

WAVE LIFE SCIENCES LTD.’s own tally for this item (“6. On a non-binding, advisory basis only, the compensation of the Company's named executive officers, in the manner and on the basis set forth described in the Proxy Statement, with the final votes cast”): 94,163,361 for, 356,573 against — passed, per its Form 8-K filed August 12, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 6 - Shareholders approved on a non-binding, advisory basis only, the compensation of the Company's named executive officers, in the manner and on the basis set forth described in the Proxy Statement, with the final votes cast as follows:”
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 40 asset managers voting on “TO APPROVE, BY A NON-BINDING ADVISORY VOTE, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS AS DISCLOSED IN T” at WAVE LIFE SCIENCES LTD., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock3,198,0300 00For
PRIMECAP Odyssey Funds2,544,7000 00For
Fidelity2,434,2230 00For
Vanguard1,851,6790 00For
T. Rowe Price1,420,5910 00For
Principal478,5670 00For
Charles Schwab356,0920 00For
SEI222,6820 00For
TIAA215,3110 00For
Prudential/PGIM158,6280 00For
QUANTITATIVE MASTER SERIES LLC154,3850 00For
John Hancock81,9930 00For
Delaware/Macquarie81,9550 00For
Equitable66,0520 00For
Lincoln Financial50,1000 00For
Putnam48,5930 00For
AIG/SunAmerica45,2760 00For
Northern Trust38,5540 00For
Global X33,2800 00For
State Street31,2780 00For
New York Life29,9280 00For
Pacific Life29,6600 00For
Nationwide26,3680 00For
Columbia Threadneedle25,9940 00For
Voya22,8830 00For

Fund voting reports, all 40 managers: 13,763,398 for, 7,654 against. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 115 asset managers voting on “TO APPROVE, BY A NON-BINDING ADVISORY VOTE, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS AS DISCLOSED IN T” at WAVE LIFE SCIENCES LTD., 2024-2025
Asset managerForAgainst AbstainWithheldVote
RA CAPITAL MANAGEMENT, L.P.18,202,0090 00For
MAVERICK CAPITAL LTD7,044,7780 00For
M28 Capital Management LP6,500,0000 00For
ADAGE CAPITAL PARTNERS GP, L.L.C.5,339,1030 00For
Siren, L.L.C.4,500,0000 00For
Kynam Capital Management, LP3,932,5500 00For
BlackRock3,297,90114,870 00For
PRIMECAP MANAGEMENT CO/CA/2,701,2840 00For
GEODE CAPITAL MANAGEMENT, LLC1,934,7550 00For
T. Rowe Price1,853,4800 00For
State Street1,469,114438 00For
EMERALD ADVISERS, LLC1,309,6890 00For
EMERALD MUTUAL FUND ADVISERS TRUST1,124,9240 00For
Point721,064,2390 00For
Affinity Asset Advisors, LLC805,6890 00For
DRIEHAUS CAPITAL MANAGEMENT LLC713,7960 00For
Laurion Capital Management LP671,5800 00For
Fidelity603,4600 00For
PLATINUM INVESTMENT MANAGEMENT LTD537,3450 00For
Connor, Clark & Lunn Investment Management Ltd.507,5160 00For
Newtyn Management, LLC500,0000 00For
SILVERARC CAPITAL MANAGEMENT, LLC385,4710 00For
Wellington381,9840 00For
JPMorgan371,8560 00For
Charles Schwab356,0920 00For

Institutional-manager reports, all 115 managers: 69,163,947 for, 280,434 against, 361 not voted. Showing the 25 largest; every one is in the interactive database (link above).

The re-appointment of KPMG LLP to serve as the Company's independent registered public accounting firm and independent…

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 2 wordings of this item as funds reported it.

99.7% Approved · of votes cast

FOR 99.7%
FOR: 101,761,729AGAINST: 316,576
Details: description as filed, official tally, votes by 40 asset managers

Description as filed by funds: To approve the re-appointment of KPMG LLP to serve as our independent registered public accounting firm and independent Singapore auditor for the year ending December 31, 2024, and to authorize the Audit Committee of the Board of Directors to fix KPMG LLP's remuneration for services provided through the date of our 2025 Annual General Meeting of Shareholders

WAVE LIFE SCIENCES LTD.’s own tally for this item (“2. The re-appointment of KPMG LLP to serve as the Company's independent registered public accounting firm and independent Singapore auditor for the year ending December 31, 2024, and to authorize the Audit Committee of t”): 101,761,729 for, 316,576 against — passed, per its Form 8-K filed August 12, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 2 - Shareholders approved the re-appointment of KPMG LLP to serve as the Company's independent registered public accounting firm and independent Singapore auditor for the year ending December 31, 2024, and to authorize the Audit Committee of the Board of Directors to fix KPMG LLP's remuner…”
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 40 asset managers below reported 13,771,052 for.

FOR
FOR: 13,771,052
Largest asset managers voting on “To approve the re-appointment of KPMG LLP to serve as our independent registered public accounting firm and in” at WAVE LIFE SCIENCES LTD., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock3,198,0300 00For
PRIMECAP Odyssey Funds2,544,7000 00For
Fidelity2,434,2230 00For
Vanguard1,851,6790 00For
T. Rowe Price1,420,5910 00For
Principal478,5670 00For
Charles Schwab356,0920 00For
SEI222,6820 00For
TIAA215,3110 00For
Prudential/PGIM158,6280 00For
QUANTITATIVE MASTER SERIES LLC154,3850 00For
John Hancock81,9930 00For
Delaware/Macquarie81,9550 00For
Equitable66,0520 00For
Lincoln Financial50,1000 00For
Putnam48,5930 00For
AIG/SunAmerica45,2760 00For
Northern Trust38,5540 00For
Global X33,2800 00For
State Street31,2780 00For
New York Life29,9280 00For
Pacific Life29,6600 00For
Nationwide26,3680 00For
Columbia Threadneedle25,9940 00For
Voya22,8830 00For

Showing the 25 largest of 40 asset managers. All 40 are in the interactive database (link above).

Largest WAVE LIFE SCIENCES LTD. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 122,479,289 shares outstanding at the time of that meeting.

Fund voting reports: top WAVE LIFE SCIENCES LTD. shareholders by shares voted on “TO APPROVE, BY A NON-BINDING ADVISORY VOTE, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS AS…”, 2024-2025
#Asset manager % of shares outstanding
1BlackRock 2.61%
2PRIMECAP Odyssey Funds 2.08%
3Fidelity 1.99%
4Vanguard 1.51%
5T. Rowe Price 1.16%
6Principal 0.39%
7Charles Schwab 0.29%
8SEI 0.18%
9TIAA 0.18%
10Prudential/PGIM 0.13%
Institutional-manager reports: top WAVE LIFE SCIENCES LTD. shareholders by shares voted on “TO APPROVE, BY A NON-BINDING ADVISORY VOTE, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS AS…”, 2024-2025
#Asset manager % of shares outstanding
1RA CAPITAL MANAGEMENT, L.P. 14.86%
2MAVERICK CAPITAL LTD 5.75%
3M28 Capital Management LP 5.31%
4ADAGE CAPITAL PARTNERS GP, L.L.C. 4.36%
5Siren, L.L.C. 3.67%
6Kynam Capital Management, LP 3.21%
7BlackRock 2.70%
8PRIMECAP MANAGEMENT CO/CA/ 2.21%
9GEODE CAPITAL MANAGEMENT, LLC 1.58%
10T. Rowe Price 1.51%

Reported WAVE LIFE SCIENCES LTD. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

WAVE LIFE SCIENCES LTD. holdings and ownership disclosed for the 2024-2025 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
RA Capital Management, L.P.34,225,506 27.94%Schedule 13D, filed April 17, 2026
BlackRock9,628,612 7.86%Form 13F, quarter ended March 31, 2025
Maverick Capital, Ltd.8,261,242 6.75%Schedule 13G, filed February 14, 2025
T. Rowe Price4,125,291 3.37%Form 13F, quarter ended March 31, 2025
Vanguard Group3,206,403 2.62%Form 13F, quarter ended March 31, 2025
Geode Capital2,592,399 2.12%Form 13F, quarter ended March 31, 2025
State Street2,417,963 1.97%Form 13F, quarter ended March 31, 2025
FMR (Fidelity)2,144,827 1.75%Form 13F, quarter ended March 31, 2025
Morgan Stanley1,179,927 0.96%Form 13F, quarter ended March 31, 2025
JPMorgan Chase1,178,937 0.96%Form 13F, quarter ended March 31, 2025

Percentages above are of 122,479,289 shares outstanding, as reported by WAVE LIFE SCIENCES LTD. on its Form 10-Q dated June 30, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At WAVE LIFE SCIENCES LTD.'s shareholder meeting held August 6, 2024, in the 2024-2025 proxy season, 141 asset managers reported votes on at least one of its 14 ballot items in their SEC Form N-PX filings, covering 1,817 separate fund positions. On the most widely held item on that ballot — TO APPROVE, BY A NON-BINDING ADVISORY VOTE, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS AS… — WAVE LIFE SCIENCES LTD.'s filing reports the proposal as approved, with 99.6% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: WAVE LIFE SCIENCES LTD.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on August 12, 2024.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from WAVE LIFE SCIENCES LTD.’s 10-Q dated June 30, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

WAVE LIFE SCIENCES LTD. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.

Cite this page

Proxy Votes Now, “WAVE LIFE SCIENCES (WVE) 2024 Annual Meeting (2024-2025 season)”, https://proxyvotesnow.com/company/wave-life-sciences-ltd/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.